Minerva Neurosciences (NERV) Competitors

$2.68

+0.08 (+3.08%)

(As of 10/9/2024 ET)

NERV vs. HTBX, IMRX, BIVI, EPRX, SPRO, RAPT, ANL, DBVT, ENTX, and VHAQ

Should you be buying Minerva Neurosciences stock or one of its competitors? The main competitors of Minerva Neurosciences include Heat Biologics (HTBX), Immuneering (IMRX), BioVie (BIVI), Eupraxia Pharmaceuticals (EPRX), Spero Therapeutics (SPRO), RAPT Therapeutics (RAPT), Adlai Nortye (ANL), DBV Technologies (DBVT), Entera Bio (ENTX), and Viveon Health Acquisition (VHAQ). These companies are all part of the "medical" sector.

Minerva Neurosciences vs.

Minerva Neurosciences (NASDAQ:NERV) and Heat Biologics (NASDAQ:HTBX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

: Minerva Neurosciences presently has a consensus price target of $5.00, indicating a potential upside of 92.31%. Given Minerva Neurosciences' higher possible upside, analysts clearly believe Minerva Neurosciences is more favorable than Heat Biologics.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Minerva Neurosciences
0 Sell rating(s)
1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Heat Biologics
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Minerva Neurosciences N/A N/A -$30M -$4.47 -0.58
Heat Biologics N/A N/A N/A N/A N/A
: Minerva Neurosciences received 347 more outperform votes than Heat Biologics when rated by MarketBeat users. Likewise, 58.61% of users gave Minerva Neurosciences an outperform vote while only 0.00% of users gave Heat Biologics an outperform vote.
Company Underperform Outperform
Minerva Neurosciences Outperform Votes
347
58.61%
Underperform Votes
245
41.39%
Heat Biologics Outperform Votes
No Votes
Underperform Votes
111
100.00%
: Company Net Margins Return on Equity Return on Assets
Minerva Neurosciences N/A N/A -62.06%
Heat Biologics N/A N/A N/A
: In the previous week, Minerva Neurosciences had 1 more articles in the media than Heat Biologics. MarketBeat recorded 1 mentions for Minerva Neurosciences and 0 mentions for Heat Biologics. Heat Biologics' average media sentiment score of 0.32 beat Minerva Neurosciences' score of 0.00 indicating that Heat Biologics is being referred to more favorably in the news media.
Company Overall Sentiment
Minerva Neurosciences Neutral
Heat Biologics Neutral
: 34.6% of Minerva Neurosciences shares are owned by institutional investors. 6.4% of Minerva Neurosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Minerva Neurosciences	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Heat Biologics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Minerva Neurosciences	N/A	N/A	-$30M	-$4.47	-0.58
Heat Biologics	N/A	N/A	N/A	N/A	N/A

Company	Underperform	Outperform
Minerva Neurosciences	Outperform Votes 347 58.61%	Underperform Votes 245 41.39%
Heat Biologics	Outperform Votes No Votes	Underperform Votes 111 100.00%

Company	Net Margins	Return on Equity	Return on Assets
Minerva Neurosciences	N/A	N/A	-62.06%
Heat Biologics	N/A	N/A	N/A

Company	Overall Sentiment
Minerva Neurosciences	Neutral
Heat Biologics	Neutral

Summary

Minerva Neurosciences beats Heat Biologics on 6 of the 8 factors compared between the two stocks.

Ad StockEarnings

These 5 stocks could soar after November 4th

Earnings Season: Your FREE Ticket to Trading Success Don't just survive earnings season - learn how to potentially thrive. Discover how to time your trades for maximum potential profit. Bonus: Daily earnings updates delivered straight to your inbox.

Click here now to claim your free guide before this offer expires!

Get Minerva Neurosciences News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NERV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NERV vs. The Competition

Export to Excel

Metric	Minerva Neurosciences	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	$18.18M	$7.16B	$5.34B	$8.42B
Dividend Yield	N/A	7.85%	4.68%	4.13%
P/E Ratio	-0.58	18.81	136.93	18.48
Price / Sales	N/A	250.06	1,208.78	73.96
Price / Cash	N/A	39.05	37.82	33.51
Price / Book	-0.64	5.78	4.80	4.79
Net Income	-$30M	$150.26M	$113.94M	$225.02M
7 Day Performance	-3.70%	3.46%	1.31%	2.45%
1 Month Performance	-5.63%	21.24%	14.56%	11.79%
1 Year Performance	-60.00%	18.39%	23.81%	19.77%

Minerva Neurosciences Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NERV Minerva Neurosciences	3.7166 of 5 stars	$2.68 +3.1%	$5.00 +86.6%	-61.5%	$18.74M	N/A	-0.60	9	Analyst Forecast
HTBX Heat Biologics	N/A	N/A	N/A	N/A	$61.05M	N/A	0.00	49	Analyst Forecast News Coverage
IMRX Immuneering	3.0171 of 5 stars	$2.47 +4.2%	$12.60 +410.1%	-67.1%	$73.24M	$320,000.00	-1.32	60
BIVI BioVie	2.7581 of 5 stars	$1.19 +0.8%	$4.00 +236.1%	-66.9%	$72.79M	N/A	-1.27	10	Positive News Gap Down
EPRX Eupraxia Pharmaceuticals	N/A	$2.65 +2.3%	N/A	N/A	$72.30M	N/A	-2.65	29	Gap Up
SPRO Spero Therapeutics	4.8544 of 5 stars	$1.30 +0.8%	$7.00 +438.5%	+8.8%	$70.19M	$103.78M	3.02	150
RAPT RAPT Therapeutics	3.6609 of 5 stars	$2.00 +0.5%	$18.17 +808.3%	-87.6%	$69.80M	$1.53M	-0.65	80	Positive News
ANL Adlai Nortye	2.1364 of 5 stars	$1.88 -6.0%	$19.50 +937.2%	-81.9%	$69.37M	$5M	0.00	127	Gap Down
DBVT DBV Technologies	2.9152 of 5 stars	$0.70 +2.9%	$4.00 +471.4%	-70.2%	$67.55M	$15.73M	-0.83	80	Gap Up High Trading Volume
ENTX Entera Bio	1.9282 of 5 stars	$1.87 +1.6%	$10.00 +434.8%	+151.7%	$66.92M	$57,000.00	-6.68	20	Analyst Forecast Gap Up
VHAQ Viveon Health Acquisition	N/A	$10.00 flat	N/A	N/A	$66.49M	N/A	0.00	2